Nerve damage in Mycobacterium ulcerans-infected mice: Probable cause of painlessness in buruli ulcer

American Journal of Pathology

Volumn 168, Issue 3, 2006, Pages 805-811

  Goto, Masamichi ^a   Nakanaga, Kazue ^b   Aung, Thida ^a   Hamada, Tomofumi ^a   Yamada, Norishige ^a   Nomoto, Mitsuharu ^a   Kitajima, Shinichi ^c   Ishii, Norihisa ^b   Yonezawa, Suguru ^a   Saito, Hajime ^d  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^d Hiroshima Environment and Health Association   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MYCOLACTONE; MYELIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BURULI ULCER; CONTROLLED STUDY; ENDONEURIUM; FOOT PAD; GENE AMPLIFICATION; MICRODISSECTION; MOUSE; MOUSE STRAIN; MYCOBACTERIOSIS; MYCOBACTERIUM ULCERANS; NERVE CELL DEGENERATION; NERVE INJURY; NONHUMAN; PAIN; PERINEURIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHWANN CELL; SKIN EDEMA; TISSUE SECTION;

EID: 33644652848     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050375     Document Type: Article

References (32)

1. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K: Mycobacterium ulcerans infection. Lancet 1999, 354:1013-1018
2. Buruli ulcer disease: Mycobacterium ulcerans infection. Wkly Epidemiol Rec 2003, 78:163-168
3. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, Small PL: Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999, 283:854-857
4. MacCallum P, Tolhurst JC, Buckle G, Sissons HA: A new mycobacterial infection in man. J Pathol Bacteriol 1948, 60:92-122
5. Ng V, Zanazzi G, Timpl R, Talts JF, Salzer JL, Brennan PJ, Rambukkana A: Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 2000, 103:511-524
6. Mwanatambwe M, Yajima M, Etuaful S, Fukunishi Y, Suzuki K, Asiedu K, Yamada N, Asanao G: Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions: first demonstration by immuno-histochemistry. Int J Lepr Other Mycobact Dis 2002, 70:201-205
7. Fujiwara T, Minagawa F, Sakamoto Y, Douglas JT: Epitope mapping of twelve monoclonal antibodies against the phenolic glycolipid-I of M. leprae. Int J Lepr Other Mycobact Dis 1997, 65:477-486
8. Guimaraes-Peres A, Portaels F, de Rijk P, Fissette K, Pattyn SR, van Vooren J, Fonteyne P: Comparison of two PCRs for detection of Mycobacterium ulcerans. J Clin Microbiol 1999, 37:206-208
9. Matsuoka M, Maeda S, Kai M, Nakata N, Chae GT, Gillis TP, Kobayashi K, Izumi S, Kashiwabara Y: Mycobacterium leprae typing by genomic diversity and global distribution of genotypes. Int J Lepr Other Mycobact Dis 2000, 68:121-128
10. Ochoa J: Isoniazid neuropathy in man: quantitative electron microscope study. Brain 1970, 93:831-850
11. Nisar M, Watkin SW, Bucknall RC, Agnew RA: Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine. Thorax 1990, 45:419-420
12. Tugwell P, James SL: Peripheral neuropathy with ethambutol. Postgrad Med J 1972, 48:667-670
13. Shin SS, Hyson AM, Castaneda C, Sanchez E, Alcantara F, Mitnick CD, Fawzi MC, Bayona J, Farmer PE, Kim JY, Furin JJ: Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2003, 7:347-353
14. Orrell RW, King RH, Bowler JV, Ginsberg L: Peripheral nerve granuloma in a patient with tuberculosis. J Neurol Neurosurg Psychiatry 2002, 73:769-771
15. Hayman JA, Smith IM, Flood P: Pseudoepitheliomatous hyperplasia in Mycobacterium ulcerans infection. Pathology 1996, 28:131-134
16. Mwanatambwe M, Fukunishi Y, Yajima M, Suzuki K, Asiedu K, Etuafel S, Yamada N, Asano G: Clinico-histopathological findings of Buruli ulcer. Nihon Hansenbyo Gakkai Zasshi 2000, 69:93-100
17. Pattyn SR: Bacteriologie et pathologie humaine et experimentale des ulceres a Mycobacterium ulcerans. [Bacteriology and human and experimental pathology of ulcers caused by Mycobacterium ulcerans]. Ann Soc Belg Med Trop 1965, 45:121-129
18. Read JK, Heggie CM, Meyers WM, Connor DH: Cytotoxic activity of Mycobacterium ulcerans. Infect Immun 1974, 9:1114-1122
19. Bentoucha A, Robert J, Dega H, Lounis N, Jarlier V, Grosset J: Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother 2001, 45:3109-3112
20. Dega H, Bentoucha A, Robert J, Jarlier V, Grosset J: Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice. Antimicrob Agents Chemother 2002, 46:3193-3196
21. Dhople AM: In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans. Int J Antimicrob Agents 2001, 17:57-61
22. Nakanaga K, Saito H, Ishii N, Goto M: Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice. Kekkaku 2004, 79:333-339
23. Morris-Jones S, Weber M: Medical mystery: painless ulcers-the answer. N Engl J Med 2004, 350:2313-2314; discussion 2313-2314
24. Chandi SM, Chacko CJ: An ultrastructural study of dermal nerves in early human leprosy. Int J Lepr Other Mycobact Dis 1987, 55:515-520
25. Kimura T: A morphological study of nerve biopsies in leprous neuropathy. Nihon Hansenbyo Gakkai Zasshi 2001, 70:141-144
26. George KM, Pascopella L, Welty DM, Small PL: A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 2000, 68:877-883
27. Daniel AK, Lee RE, Portaels F, Small PL: Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone. Infect Immun 2004, 72:123-132
28. Walsh DS, Meyers WM, Krieg RE, Walsh GP: Transmission of Mycobacterium ulcerans to the nine-banded armadillo. Am J Trop Med Hyg 1999, 61:694-697
29. Oliveira MS, Fraga AG, Torrado E, Castro AG, Pereira JP, Filho AL, Milanezi F, Schmitt FC, Meyers WM, Portaels F, Silva MT, Pedrosa J: Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect Immun 2005, 73:6299-6310
30. Coutanceau E, Marsollier L, Brosch R, Perret E, Goossens P, Tanguy M, Cole ST, Small PL, Demangel C: Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol 2005, 7:1187-1196
31. Mve-Obiang A, Lee RE, Portaels F, Small PL: Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect Immun 2003, 71:774-783
32. Krieg RE, Hockmeyer WT, Connor DH: Toxin of Mycobacterium ulcerans: production and effects in guinea pig skin. Arch Dermatol 1974, 110:783-788